Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Total Stockholders’ Equity	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Cumulative Net Income	Cumulative Dividends	Non-controlling Interests
Beginning balance at Dec. 31, 2021	$ 2,185,116	$ 2,185,116	$ 1,505	$ 3,972,917	$ (9,981)	$ 1,266,158	$ (3,045,483)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	22,661	22,661	7	22,654
Common stock redemptions	(206)	(206)		(206)
Share-based compensation	3,699	3,699	4	3,695
Net (loss) income	42,227	42,227				42,227
Reclassification adjustments for (gains) losses included in net income (interest expense)	1,086	1,086			1,086
Gains (Losses) arising during the period on interest rate swaps	5,159	5,159			5,159
Dividends to common stockholders (in usd per share)	(46,860)	(46,860)					(46,860)
Ending balance at Mar. 31, 2022	2,212,882	2,212,882	1,516	3,999,060	(3,736)	1,308,385	(3,092,343)	0
Beginning balance at Dec. 31, 2022	7,679,818	7,571,076	3,806	9,587,637	2,140	1,307,055	(3,329,562)	108,742
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	51	51		51
Common stock redemptions	(1,484)	(1,484)	(1)	(1,483)
Share-based compensation	4,992	4,992	3	4,989
Net (loss) income	(88,078)	(87,125)				(87,125)		(953)
Reclassification adjustments for (gains) losses included in net income (interest expense)	(2,284)	(2,256)			(2,256)			(28)
Gains (Losses) arising during the period on interest rate swaps	(8,541)	(8,438)			(8,438)			(103)
Dividends to common stockholders (in usd per share)	(119,635)	(118,188)					(118,188)	(1,447)
Ending balance at Mar. 31, 2023	$ 7,464,839	$ 7,358,628	$ 3,808	$ 9,591,194	$ (8,554)	$ 1,219,930	$ (3,447,750)	$ 106,211